GFM
VNDA icon

GF Fund Management’s Vanda Pharmaceuticals VNDA Stock Holding History

GF Fund Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.55K Sell
1,234
-93
-7% -$608 ﹤0.01% 553
2026
Q1 		$9.17K Buy
1,327
+187
+16% +$1.44K ﹤0.01% 567
2025
Q4 		$10.1K Sell
1,140
-113
-9% -$622 ﹤0.01% 574
2025
Q3 		$6.25K Sell
1,253
-240
-16% -$1.11K ﹤0.01% 594
2025
Q2 		$7.05K Hold
1,493
– – ﹤0.01% 603
2025
Q1 		$6.85K Buy
1,493
+269
+22% +$1.25K ﹤0.01% 603
2024
Q4 		$5.86K Buy
+1,224
New +$5.88K ﹤0.01% 603

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GF Fund Management's VNDA Position: Q2 2026 in Review

GF Fund Management reduced its Vanda Pharmaceuticals (VNDA) stake by 7% in Q2 2026, selling an estimated $608 and leaving 1,234 shares worth $7.55K. The position accounts for ﹤0.01% of the portfolio, ranked #553.

GF Fund Management first reported a position in VNDA in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.1K in Q4 2025. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • GF Fund Management held 1,234 shares of Vanda Pharmaceuticals worth $7.55K as of Q2 2026.
  • GF Fund Management sold 93 Vanda Pharmaceuticals shares in Q2 2026, an estimated $608.
  • Vanda Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #553 holding.
  • GF Fund Management first reported a position in Vanda Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Vanda Pharmaceuticals position peaked at $10.1K in Q4 2025.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.